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Chronic venous ulcers are characterized by chronic in-
£ammation. Heme and iron, originating from blood
cell hemolysis as well as extravascular necrosis, have
been implicated as important pathogenic factors due to
their promotion of oxidative stress. It was recently re-
ported that the plasma and tissue protein a1-microglo-
bulin is involved in heme metabolism. The protein
binds heme, and a carboxy-terminally processed form,
truncated a1-microglobulin, also degrades heme. Here,
we show the presence of micromolar levels of heme and
free iron in chronic leg ulcer £uids. Micromolar
amounts of a1-microglobulin was also present in the ul-
cer £uids and bound to added radiolabeled heme. Trun-
cated a1-microglobulin was found in the ulcer £uids
and exogenously added a1-microglobulin was processed
into the truncated a1-microglobulin form. Histochem-
ical analysis of chronic wound tissue showed the pre-
sence of iron deposits, heme/porphyrins in in¢ltrating
cells basement membranes and ¢brin cu¡s around ves-
sels, and a1-microglobulin ubiquitously distributed but
especially abundant in basement membranes around
vessels and at ¢brin cu¡s. Our results suggest that a1-
microglobulin constitutes a previously unknown de-
fense mechanism against high heme and iron levels
during skin wound healing. Excessive heme and iron,
which are not bu¡ered by a1-microglobulin, may
underlie the chronic in£ammation in chronic ulcers.
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W
ound healing is a complex process encompass-
ing phases of in£ammation, granulation tissue
formation, angiogenesis, and epithelialization.
Aberrant and defective wound healing occurs
in patients with chronic ulcers. This condition
represents a major health problem and an increasing burden to
health care providers. The major group of ulcers, venous leg ul-
cers, are characterized by persistent and unregulated chronic in-
£ammation, involving extravasation of in£ammatory cells,
release of proteases and degradation of matrix molecules, growth
factors, and other constituents (—gren et al, 2000; Falanga, 2001).
Several causative mechanisms underlying the chronic in£am-
mation have been proposed. The sustained venous pressure of
these patients leads to a reduced pressure di¡erential between the
arterial and venous systems, thus trapping leukocytes in the con-
nective tissue. Extravasation of leukocytes also occurs in nonulcer
patients with venous disease and may lead to ulcer formation
(Wilkinson et al, 1993). Extravasation of ¢brin lead to the forma-
tion of ¢brin depositions (¢brin cu¡s), possibly trapping and in-
activating growth factors involved in wound healing in the
perivascular areas (Falanga, 2001). Furthermore, all chronic ulcers
are constantly colonized or infected by various bacteria such as
Pseudomonas aeruginosa, Escherichia faecalis, and P. mirabilis and recent
evidence supports the view that high bacterial loads contribute to
nonhealing (Davies et al, 2001).
Iron, in free form or complex-bound to protoporphyrin IX in
heme, has been implicated as an important pathogenic factor in
in£ammation in general and in leg ulcers in particular (Ackerman
et al, 1988;Wagener et al, 2001;Wenk et al, 2001). The oxidized fer-
ric (Fe3þ) forms of heme and free iron are strong oxidative
agents and the ferrous iron (Fe2þ ) can generate oxygen-derived
free radicals by the Fenton reaction (Halliwell and Gutteridge,
1989). These compounds present considerable oxidative stress that
leads to tissue damage and cell destruction, and have been pro-
posed to participate in the pathogenesis of chronic ulcers (for a
review, see —gren et al, 2000) by initiating local lipid peroxidation
of polyunsaturated fatty acids in cell membranes as well as enhan-
cing the synthesis and activation of matrix-degrading metallo-
proteinases.
a1-Microglobulin (a1m) is a 26 kDa glycoprotein that is evolu-
tionarily well-conserved and has so far been found in mammals,
birds, ¢sh, and amphibians (—kerstr˛m and L˛gdberg, 1990;
—kerstr˛m et al, 2000b). It belongs to the lipocalin superfamily, a
group of proteins from animals, plants, and bacteria with very
diverse functions but a well-conserved three-dimensional struc-
ture (—kerstr˛m et al, 2000a). The lipocalins consist of a 160 to
190 amino acid polypeptide folded into an eight-stranded b-bar-
rel surrounding a pocket that can bind hydrophobic ligands.
About half of the a1m-molecules are complex-bound to IgA
(Grubb et al, 1986). Both free and IgA-bound a1m are found in
most tissues intravascularly and extravascularly. It was recently
shown that a1m has heme-binding properties and may be in-
volved in extracellular heme catabolism (Allhorn et al, 2002). For-
mation of a processed form of a1m, lacking the C-terminal
tetrapeptide LIPR (leucine-isoleucine-proline-arginine), is in-
duced by hemoglobin. This processed a1m form, called t-a1m
(t¼ truncated), has both heme-binding and heme-degrading
properties. The results indicate a protective role of a1m against
heme-induced oxidative damage. Considering the proposed
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pathogenic role of heme, we have investigated concentration, dis-
tribution, and biochemical properties of a1m in wound £uids
from chronic venous leg ulcers. It is shown that a1m is ubiqui-
tously distributed in wound sections, that it is a heme-binding
protein in ulcer £uids, and that t-a1m is formed. These results
are consistent with a protective role of a1m in the ulcer £uids as
a heme antagonist.
MATERIALS AND METHODS
Patients, wound £uid, and plasma Wound £uid and plasma were
collected from patients with venous ulcers. Wound £uid was collected
either by sampling on ¢lters as described previously (Schmidtchen, 1999,
2000) or under a Tegaderm dressing (Schmidtchen, 2000). In the ¢rst
procedure (used in experiments described in Fig 1; sampling from a
group of 12 patients), sterilized ¢lters (Whatman GF/D; diameter 2.5 cm)
were applied to wounds for 4 h and wound £uid was extracted from the
¢lter. Proteinase activity was blocked by the addition of the proteinase
inhibitors diisopropyl phosphoro£uoridate, N-ethylmaleimide, and
ethylenediamine tetraacetic acid (Schmidtchen, 2000). The ¢lters did not
induce degradation of a1-m in human plasma (not shown). Wound £uid
from 12 patients with venous ulcers (43 mo duration) was used for the
experiments. In the second procedure (used for all other experiments),
Tegaderm dressings were applied on the wound and wound £uid was
collected by gentle aspiration underneath the ¢lm after 2 h, centrifuged at
10,000 r.p.m. (3500 g) in an Eppendorf centrifuge, aliquoted and stored
at ^201C until further use. The venous insu⁄ciency was routinely
determined either by a handheld Doppler (5 MHz probe; examination of
re£ux in the politeal vein, great saphenous vein and small saphenous vein)
or by color duplex examination. The patients had a systolic index of more
than 0.8. Patients with diabetes or signs of general infection (malaise, fever)
or local infection (cellulitis, erysipelas) were excluded. Plasma from healthy
volunteers was collected by intravenous puncture. The research project was
approved by the local Ethics Committee. Informed consent was obtained
from the patients.
Proteins and reagents Human plasma a1mwas prepared from plasma as
described previously (—kerstr˛m et al, 1995; Berggrd et al, 1997, 1999).
Protein LG was a generous gift from Dr Lars Bj˛rck, Department of Cell
and Molecular Biology, Lund University, Sweden, and was coupled to
CNBr-activated Sepharose-4B (Pharmacia-Biotech, Uppsala, Sweden), 7
mg per mL gel, as described by Pharmacia-Biotech. Orosomucoid,
human albumin and other chemicals were from Sigma-Aldrich
Stockholm, Sweden AB if not indicated otherwise. Mouse monoclonal
anti-human a1m antibody was raised as described (Nilson et al, 1987).
Rabbit anti-serum against human a1m was prepared in this laboratory by
following the earlier description (Berggrd and Bearn, 1968). Rabbit anti-
LIPR was prepared by AgriSera AB (Vnns, Sweden) by immunization
with the synthetic peptide CKKLIPR conjugated to keyhole limpet
hemocyanin (KLH). The preparation of goat anti-rabbit immunoglobulins
has been described previously (Bj˛rck et al, 1977). Proteins were labeled
with [125I]iodide (Bio-Nuclear AB, Stockholm, Sweden) using the
chloramine T method (Greenwood et al, 1963). Labeled proteins were
separated from free iodide by gel ¢ltration on Sephadex G-25 column
(Pharmacia). The speci¢c activity was approximately 0.5 MBq per mg
protein.
Sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and immunoblotting of a1m in wound £uids and
plasma The molecular forms of a1m in wound £uids and plasma were
investigated by SDS^PAGE and immunoblotting. SDS^PAGE was
performed under denaturing conditions using 12% gels in the bu¡er
system described by Laemmli (1970). Samples mixed with sample bu¡er
1:1 (v/v) containing 2% (v/v) b-mercaptoethanol and SDS were boiled 3
min before loading to the gel. High molecular mass standards (Rainbow
markers, Amersham, International plc, Amersham, Buckinghamshire,
England) were used. The gels were stained with Coomassie Brilliant Blue
R-250 (BDH Chemicals, Ltd, Poole, UK) and dried. In some cases 3% to
12% polyacrylamide gradient gels with a 3% stacking gel were used. The
separated proteins were transferred to polyvinylidene £uoride membranes
(Immobilon, Millipore, Bedford, Massachusetts) as described (Matsudaira,
1987). Immunoblotting was performed as previously described
(Schmidtchen, 1999) using polyclonal anti-sera against a1m diluted 1000
times. The membranes were developed using the ECL system
(Boehringer, Mannheim GmbH, Mannheim, Germany).
A⁄nity chromatography of wound £uids To distinguish between
full-length a1m and t-a1m, i.e., the form of the protein that lacks the C-
terminal tetrapeptide LIPR, a1m was puri¢ed from wound £uids by anti-
a1m a⁄nity chromatography and subsequently immunoblotted both with
antibodies against full-length a1m and antibodies against LIPR. A⁄nity
chromatography was performed according to an earlier description
(Allhorn et al, 2002), using mouse monoclonal anti-a1m, BN11.10, which
had been immobilized to A⁄gel Hz (Bio-Rad Laboratories, Hercules,
California) at 20 mg per mL following instructions from the merchant.
The eluted proteins were separated by SDS^PAGE and identi¢ed by
immunoblotting (see above) using anti-a1m diluted 1000 times or anti-
LIPR diluted 300 times. The blots were developed by incubation with
125I-goat anti-rabbit immunoglobulin as described (Wester et al, 1997) and
analysis with a Fuji Bas 2000 Bio-imaging analyzer (Fuji Films Co., Japan).
Cleavage of a1m by wound £uids The cleaving activity of wound
£uids was tested by adding small amounts of radiolabeled a1m. One Bq
of 125I-a1m or
125I-IgA-a1m was added to 1 mL wound £uid (10 mg total
proteins as measured by the Bradford method) diluted in phosphate-
bu¡ered saline (PBS: 10 mM phosphate bu¡er, pH 7.4, 120 mM NaCl, 3
mM KCl). The reaction proceeded for 1 h at room temperature. The
samples were then applied to SDS^PAGE and the dried gel analyzed with
a Fuji Bas 2000 Bio-imaging analyzer.
Binding of [14C]heme to a1m in wound £uids [
14C]heme was
produced using the Escherichia coli strain AN344 containing the plasmid
pTYR13 as described by Schi˛tt et al, 1997). AN344 is blocked in delta-
amino levulnic acid (ALA) synthesis and requires ALA for growth. Thus,
the addition of 31 mM (50.8 Ci per mol) [4 -14C]ALA (New England
Nuclear Inc., Boston, MA) to strain AN344/pTYR13 in Luria broth (LB)
medium resulted in production of [14C]heme with the yield 20 nmol per
60 mL culture and with a speci¢c activity of 2.5 Ci per mmol. [14C]heme
(15 pmol) was incubated with 1.5 mL wound £uid (15 mg total proteins as
measured by the Bradford method) with or without added a1m (45 pmol)
or albumin (45 pmol), or incubated with these amounts of a1m or albumin
alone, diluted in PBS þ 0.05% Tween-20 to 10 mL. After 30 min at 201C,
SDS^PAGE sample bu¡er was added and the samples analyzed by SDS^
PAGE as described above, the gels dried and the radioactivity analyzed
with a Fuji Bas 2000 Bio-imaging analyzer.
Figure1. a1m in wound £uids and plasma. Twelve samples of wound
£uid (A) and plasma, diluted 200 (B) indicated with numbers 3 to 14,
each 10 mg total protein, were applied on SDS^PAGE, 3% to 12%, and
immunoblotted using polyclonal anti-sera against a1m. Samples from one
patient were collected during three visits (corresponding to lane numbers
1^3). Number 15 on (A) displays a normal plasma sample. Molecular
weight standards (in kDa) are indicated to the left.
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Binding of [14C]heme in HepG2 cell cultures To measure the
binding of heme to newly synthesized a1m, [
14C]heme was added to
cultures of the liver cell line HepG2, which synthesize and secrete a1m.
HepG2 cells were grown at 371C in RPMI 1640 medium (Gibco, Life
Technologies, Gaithersburg, MD) in an atmosphere of 5%. The medium
contained 10% fetal bovine serum (FBS), L-glutamine, 300 mg per mL,
and 100 mg per mL antibiotics (penicillin and streptomycin). In one
experiment, 0.03 mM Na2SeO3 was used instead of FBS, using conditions
described previously (—kerstr˛m et al, 1995). The cells were split 1:5 or 1:10
by trypsin digestion twice a week. Fresh culture medium was added to
£asks with con£uent cells, and 24 h later, [14C]heme was added to a ¢nal
concentration of 0.07 to 0.4 mM and the incubation proceeded for 3 h. The
cells were centrifuged and the medium removed and saved for
immunoprecipitation, puri¢cation of a1m by a⁄nity chromatography (see
above), and radioimmunoassay. The cells were lyzed by resuspension in 15
mL 20 mM Tris^HCl, pH 8.0, 150 mM NaCl, 0,02% NaN3, 1% Triton X-
100, 0.25% nonidet P-40, 0.25% bovine serum albumin. The suspension
was then centrifuged, 1000 r.p.m., (700g) 20 min 1 mL medium or 1 mL
cell lysate was immunoprecipitated with 10 mL of polyclonal antibody
(100 mg IgG) against a1m. As a control, 10 mL polyclonal anti-
orosomucoid (Dakopatts Glostrup, Denmark) was used. After 20 h
incubation at 41C, 30 mL protein LG-Sepharose (50% 1:1 suspension) was
added and the incubation continued for 2 h at room temperature. After
centrifugation and removal of supernatant, the immunoprecipitates were
washed several times with PBS. The pellets were ¢nally solubilized in
SDS^PAGE sample bu¡er and analyzed by SDS^PAGE. The gels were
dried and analyzed with a Fuji Bas 2000 Bio-imaging analyzer.
Biopsies Four millimeter biopsies were taken from the wound edge of a
chronic venous leg ulcer. Control biopsies were taken from the edges of
acute wounds or from healthy skin of the thigh. The tissue samples were
¢xed overnight in 4% paraformaldehyde, dehydrated sequentially in
ethanol and subsequently embedded in para⁄n. Tissue sections (5 mm)
were cut in a microtome, mounted on slides, and air dried overnight in a
371C incubator.
Immunohistochemistry Sections were depara⁄nized by routine
procedures and endogenous peroxidase activity was blocked with 3%
H2O2 in methanol for 10 min. After rinsing in distilled water, followed
by PBS, the slides were subsequently permeabilized with Tween 20
(0.05%) in PBS. Thereafter, sections were rinsed in PBS. After
preincubation with normal goat serum (1%) for 30 min at room
temperature, incubation was performed with primary antibody diluted
1:500 in PBS (containing 0.05% Tween 20, 0.2% bovine serum albumin)
overnight at 41C. Control sections were incubated in the same PBS
solution without antibody. Antibody detection was performed with
a standard avidin^biotin complex detection system after which they
were developed with 3,30,-diaminobenzidine tetrahydrochloride as
the chromogenic substrate (Vectastain avidin^biotin complex, Vector
Laboratories, Burlingame, California). Sections were counterstained with
Mayer’s Hemalum (Diagnostica Merc, Darmstadt, Germany), mounted
with Pertex (Histolab Products AB, Gothenburg, Sweden) and examined
and photographed (Olympus BHS photomicrographic system).
Iron and porphyrin staining For iron staining, para⁄n-embedded
skin sections were dewaxed and rehydrated. Iron deposition was
examined using Perls’ Prussian blue staining. The sections were incubated
in a solution containing 1% potassium ferrocyanide in 1% HCl for 1 h.
After several washes in H2O the sections were incubated with a 1%
neutral red solution for 5 min and washed again in H2O. Dehydrated and
di¡erentiated sections were mounted in DPX-type mountant. Porphyrins
were stained using Fouchet technique, the method of choice for
demonstration of bile pigments. After 5 min incubation in a reagent
containing 12.5% trichloroacetic acid and 5% aqueous ferric chloride, the
sections were washed in distilled water and counterstained with van
Gieson’s solution: saturated picric acid, 0.1% acid fuchsin, and 0.1% glacial
acetic acid, for 3 min. The sections were washed in alcohol before
dehydration.
Determination of a1m, porphyrin, and iron concentrations in
wound £uids and plasma Speci¢c concentrations of a1m were
measured by a soluble competitive radioimmunoassay (—kerstr˛m, 1985).
Protoporphyrin IX was detected using the pyridin-hemochromogen
method as described by Falk (1964). Iron concentrations were determined
by a spectrophotometric procedure with hydroxylamine and thioglycolate
as the reducing agents and ferrozine as the ferrous ion complexing agent, at
the Department of Clinical Chemistry, Malm˛ General Hospital, Malm ,˛
Sweden. The assays were performed with SYNCHRON LX Systems,
Beckman Coulter, Inc., Fullerton California.
RESULTS
a1m in wound £uids The wound £uids from 12 patients with
chronic venous ulcers contained three variants of a1m: free
monomeric a1m, t-a1m, and a1m complex-bound to IgA (IgA-
a1m) when analyzing by SDS^PAGE (Fig 1). The IgA-a1m
complex appears on SDS^PAGE as a nonreducable 90 kDa
protein band containing a1m covalently linked to the a-chain.
A large variation in the relative concentrations of the three
forms was noted. In contrast, plasma from the same patients
contained no t-a1m and displayed less variation between
individuals. Furthermore, the various high-molecular-weight
a1m complexes described previously (Berggrd et al, 1997) could
be seen in plasma samples but were absent in wound £uids.
T-a1m in wound £uids was identi¢ed by puri¢cation of a1m
on anti-human a1m a⁄nity chromatography, followed by
immunoblotting with anti-LIPR (Fig 2). The results obtained
con¢rmed that the protein band corresponding to t-a1m on
SDS^PAGE lacked the C-terminal tetrapeptide.
Cleavage of a1m The appearance of t-a1m on SDS^PAGE
prompted a further investigation of the cleaving activity of
wound £uids. Thus, 125I-a1m or
125I-IgA-a1m was added to
wound £uid samples and the mixtures were then analyzed on
SDS^PAGE. The results obtained revealed the presence of a
radioactive protein band corresponding to t-a1m, approximately
3 to 4 kDa smaller compared with native a1m (Fig 3).
125I-IgA-
a1m was also processed, which caused disappearance of the 90
kDa band and appearance of free a1m.
Binding of [14C]heme to a1m a1m was added to wound £uid
and the binding to exogenously added [14C]heme was tested
(Fig 4). A clear binding of radiolabeled heme to a1m in the
wound £uids could be seen (lane 1) and to a1m alone without
wound £uid present (lane 2). Albumin, a known physiologic
heme-binding protein, also bound the added heme when added
to wound £uid (lane 3).The binding of [14C]heme to wound £uid
without previous addition of a1m or albumin was not detected
(not shown), possibly due to low concentrations of the proteins
and/or because endogenous a1m is saturated with pre-existing
heme in the wound £uids.
Binding of [14C]heme by a1m in HepG2 cells To examine
the heme-binding properties of newly synthesized a1m not
Figure 2. a1m and t-a1m puri¢ed from wound £uids. a1m from 100
mL wound £uid, collected from each of three patients with chronic leg ul-
cers, were puri¢ed by a⁄nity chromatography on a column with immobi-
lized monoclonal antibodies against a1m. The eluates (lanes 1^3) were
electrophoresed on 10% SDS^PAGE under reducing conditions and im-
munoblotted with anti-a1m (A) and anti-LIPR (B). Lane 4 shows plasma
a1m and lane 5 corresponds to t-a1m, obtained by incubation of plasma
a1m with erythrocyte membranes as described (Allhorn et al, 2002).
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previously exposed to heme, human hepatoblastoma (HepG2)
cells were used. These cells synthesize a1m as a precursor protein,
a1m/bikunin, which is cleaved intracellularly and the proteins are
secreted separately. Thus, [14C]heme was added to the culture
medium containing newly synthesized and secreted a1m. This
medium was then immunoprecipitated with polyclonal anti-
sera. The results displayed in Fig 5(A) show that the [14C]heme
added to HepG2 cells bound to a1m, but not to orosomucoid
also synthesized by the HepG2 cells. Medium was also applied
to a monoclonal a⁄nity chromatography column and a1m
isolated by a⁄nity chromatography could be seen as a
radioactive band on SDS^PAGE (Fig 5B). The lyzed cells from
the same cultivation did not show any radioactivity on SDS^
PAGE, suggesting that there were too small amounts of
[14C]heme bound intracellularly to be detected (not shown). To
exclude the possibility that [14C]heme bound to proteins from
the FBS in the medium, FBS was replaced by Na2SeO3. In this
case the binding of [14C]heme to a1m was even more
pronounced, as indicated in Fig 5(B), possibly as a result of the
absence of competing heme-binding factors in FBS. The
synthesis rate of a1m was similar with or without FBS (not
shown).
Iron, heme, and a1m in wound £uids and sections The skin
sections from patients with chronic ulcers and from healthy
individuals were investigated histologically using polyclonal
anti-sera directed against a1m. The results revealed a global
distribution of a1m in the dermis layer, with more intense
staining in basement membranes and ¢brin cu¡s surrounding
the blood vessels (Fig 6B). The normal skin section prepared
from a healthy individual also displayed a ubiquitous
distribution of a1m with increased amounts around vessels
(Fig 6A). Porphyrin-speci¢c staining showed the presence of
porphyrins in basement membranes and ¢brin cu¡s around
vessels, i.e., a colocalization with a1m, as well as in in¢ltrating
blood cells (Fig 6C). In contrast, much less porphyrins were
found in sections from patients with acute wounds (Fig 6E) or
normal skin sections. Furthermore, pronounced iron deposits
were seen in chronic ulcers (Fig 6D), as opposed to acute
wounds or skin sections from healthy individuals, which were
negative with respect to iron (not shown). These results suggest
that tissue deposition of heme and iron is accentuated in chronic
ulcers as compared with acute wounds and normal skin, whereas
a1m is ubiquitously present both in normal skin and chronic
ulcers.
Heme (protoporphyrin IX), free iron, and a1m concentrations
were determined in wound £uids and plasma from patients with
chronic ulcers (Table I). The heme content was estimated to
Figure 3. Cleavage of exogenously added a1m in wound £uid. One
becquerel of 125I-plasma a1m (A) or
125I-IgA-a1m (B) was added to wound
£uid, 5 mg total proteins, in PBS. Lanes 1 and 2 correspond to samples be-
fore and after addition of wound £uids, respectively. After 1 h incubation at
room temperature, the samples were separated by SDS^PAGE.
Figure 4. Binding of [14C]heme to a1m in wound £uid.Wound £uid
(1.5 mL¼15 mg protein), with added 45 pmol plasma a1m (1.5 mg), was in-
cubated with 15 pmol [14C]heme in PBS, 0.05% Tween (lane 1). In lane 2,
the same amount (45 pmol) of puri¢ed plasma a1m was incubated with
[14C]heme (15 pmol) without wound £uid. As a control, 45 pmol human
albumin was incubated with 15 pmol [14C]heme in 1.5 mLwound £uid (lane
3). The samples were incubated for 30 min and then applied to SDS^PAGE
and the dried gel analyzed in a Fuji Bas 2000 Bio-imaging analyzer.
Figure 5. Binding of [14C]heme by a1m in HepG2 cells. (A) Medium
from HepG2 cells, grown in the presence of 1 nmol [14C]heme, was immu-
noprecipitated with polyclonal antia1m (lane 1) or anti-orosomucoid (lane
2). The a1m samples were then loaded on SDS^PAGE. (B) Five nanomol
[14C]heme were added to HepG2 cells grown in medium supplemented
with 10% FBS (lane 3) or 0.03 mMNa2SeO3 (lane 4). The mediumwas then
puri¢ed on an a⁄nity column with immobilized monoclonal antibodies
against a1-m and the eluates analyzed by SDS^PAGE.
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19.8 mM (SEM 6.7) in wound £uids and 13.4 mM (SEM 3.6) in
plasma. The iron concentration was 6.5 mM (SEM 2.7) in wound
£uids and 7.3 mM (1.5) in plasma. The a1m concentration was
1.7 mM (SEM 0.8) in wound £uids and 1.9 mM (SEM 1.5) in
plasma. As a control, the heme, iron, and a1m concentrations
were determined in plasma from normal donors. The heme and
a1m concentrations were 12.1 mM (SEM 3.6) and 1.8 mM (SEM 0.3),
respectively (Table I), i.e., similar values as in plasma from
patients with chronic ulcers. The iron concentration in normal
plasma was 13.9 (SEM 0.7), which is higher than in plasma and
ulcer £uids from patients with chronic wounds.
DISCUSSION
Recent results indicate that the lipocalin a1m is a heme scavenger,
and that it participates in protection against toxic e¡ects of extra-
cellularly exposed heme. Heme has been proposed as an inducer
of in£ammation and constitutes one of several pathogenic factors
in chronic leg ulcers. Chronic venous ulcers, characterized by
accumulated heme, may therefore serve as a relevant model for
investigation of physiologic interactions between a1m and heme.
The results in this study show the simultaneous presence of heme,
iron, and a1m in chronic wound £uids and a colocalization of
a1m and heme in tissue sections to basement membranes and
¢brin cu¡s around vessels. Moreover, a1m binds heme in the
wound £uids and is processed into the truncated form t-a1m,
which has heme-degrading properties. The results obtained here
Figure 6. Histochemical distribution of a1m, porphyrins, and free iron in chronic venous ulcers. a1m, porphyrins and iron in skin sections from
chronic ulcers, acute wounds and normal skin, including epidermis and dermis. (A) a1m in normal skin ( 20). (B) a1m in skin from a patient with chronic
ulcers ( 20). The sections were immunostained for a1m using polyclonal anti-serum against a1m followed by peroxidase/diaminobenzidine tetrahy-
drochloride incubation as described in Materials and Methods. a1m appears in high density in basement membranes and ¢brins cu¡s surrounding the blood
vessels (arrows). (C,  40) and (D,  40) show porphyrins and iron depositions, respectively, in the tissue from chronic leg ulcers. Porphyrins were stained
with Fouchet technique and iron with Perls’ Prussian blue stain. High-density depositions are marked with arrows. (E) Porphyrin staining in the skin section
from a patient with acute wound ( 40). The magni¢cation bars in the lower-right corner in each panel represent 0.02 mm. FC, ¢brin cu¡s, v, vessel.
Table I. Concentrations of heme (protoporphyrin IX), free
iron, and a1m in chronic wound £uids and in plasma from
patients with chronic ulcers and normal donors. Mean values
of determinations on ¢ve samples (n¼ 5) and SEM values in
each category are shown
Heme (mM) Iron (mM) a1m (mM)
Chronic ulcers
Wound £uid 19.8 (6.7) 6.5 (2.7) 1.7 (0.8)
Plasma 13.4 (3.6) 7.3 (1.5) 1.9 (1.5)
Normal plasma 12.1 (3.6) 13.9 (0.7) 1.8 (0.3)
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thus support a view of a1m as a heme scavenger during in£am-
mation.
It was previously noted that the C-terminal processing of a1m
is induced by puri¢ed hemoglobin or by membranes from
ruptured erythrocytes (Allhorn et al, 2002). It was speculated that
an oxidized form of hemoglobin, which can be found deposited
in erythrocyte membranes, may be responsible for the cleavage.
The identity of the cleaving factor(s) in the leg ulcer £uids was
not determined in this investigation; however, hemoglobin is
usually found in this type of chronic leg ulcers (Blomgren et al,
2001) and this paper as well as others (Wenk et al, 2001) has shown
the presence of heme and iron. It is therefore possible that the
processing of a1m in chronic leg ulcers is induced by hemoglo-
bin, hemoglobin variants, or free heme. We have previously
shown that t-a1m is excreted in normal urine and that urinary
t-a1m may be elevated in urine from hemolytic patients (Allhorn
et al, 2002). In analogy, an increased t-a1m formation in patients
with chronic ulcers may be re£ected as an elevated urinary t-a1m
concentration in these patients, and therefore, it is interesting to
speculate that the urinary a1m/t-a1m ratio could be a useful para-
meter for evaluation of the clinical status of the ulcer patients.
About 50% of a1m in blood is complex bound to monomeric
IgA (Grubb et al, 1986; Berggrd et al, 1997). The IgA-a1m com-
plex is also found in extravascular compartments (Berggrd et al,
1999; Bouic et al, 1985;Vincent and Revillard, 1987). It was shown
that IgA-a1m is processed by erythrocyte membranes and hemo-
globin, forming intact IgA and t-a1m (Allhorn et al, 2002).
IgA-a1m may therefore be regarded as a depot from which the
activated t-a1m is released. Leg ulcer £uids cleaved exogenously
added IgA-a1m, suggesting that a mobilization of activated,
heme-binding and heme-degrading a1m from the IgA-a1m de-
pot takes place in leg ulcers in vivo. IgA is a normal component
of skin, and granular deposits containing various forms of IgA
were found in skin from patients with dermatitis herpetiformis
(Egelrud and Bck, 1985), suggesting a role of this molecule in
homeostasis and pathology of the skin. It should therefore be of
interest to investigate the normal distribution of IgA-a1m as well
as the presence of the complex in the pathologic granular depos-
its. Other high-molecular-weight plasma forms with masses
around 200 kDa, representing complexes with albumin, pro-
thrombin, and other as yet unknown molecules, have also been
found to be associated with a1m (Berggrd et al, 1997). Interest-
ingly, these high-molecular-weight complexes are still present in
plasma from patients with chronic leg ulcers but absent in wound
£uids, as judged by SDS^PAGE.The reason for this is unclear but
demonstrates that the distribution and metabolism of the a1m
complexes are di¡erent.
The liver is the main site of synthesis of a1m and only traces of
a1m-encoding mRNA are found in other organs (Kaumeyer et al,
1986; Itoh et al, 1996; Daveau et al, 1998). No production of a1m in
keratinocytes or ¢broblasts could be detected (not shown). The
a1m and a1m complexes found in ulcer £uids therefore most
likely originate from the liver and are transported there via the
blood, rather than being synthesized locally. Plasma a1m and he-
patocyte-derived a1m could indeed bind to radiolabeled heme in
wound £uids, supporting this view (Figs 4 and 5). Such a trans-
port of a1m from blood to tissues was demonstrated experimen-
tally after injection of 125I-labeled a1m and a1m complexes
intravenously into rats (Larsson et al, 2000). The protein composi-
tion in chronic wound £uids closely resembles that of plasma
(Schmidtchen, 2000), suggesting a leakage of plasma proteins into
wounds and further supporting the notion that a1m in wound
£uids is indeed plasma derived.
Heme was found both in ulcer £uids and in plasma of ulcer
patients (Table I). Heme was also found widely distributed in tis-
sue sections from the chronic ulcers as opposed to acute wound
sections or normal skin sections (Fig 6). Owing to venous hyper-
tension in chronic ulcers (—gren et al, 2000; Falanga, 2001), a £ow
of heme from plasma to the extravascular compartments across
the endothelium and basement membranes is expected. Heme
may therefore be trapped and accumulated in the membranous
compartments of the endothelium and basement membranes
and accumulated in pericapillary ¢brin cu¡s, which probably de-
velop as a result of venous hypertension and extravasation of
¢brinogen (Van de Scheur and Falanga, 1997). Such a distribution
of heme to basement membranes and ¢brin cu¡s was indeed
found in this investigation. Interestingly, especially high amounts
of a1m were also found in these compartments (Fig 6), support-
ing the view of a1m as a heme scavenger. This localization of a1m
also agrees with previous immunohistochemical studies of skin
and placenta (Bouic et al, 1985; Berggrd et al, 1999).
Free heme, released from hemoglobin and other heme proteins
as a result of oxidation, generates reactive oxygen species leading
to subsequent cell and tissue damage. Excess accumulation of
heme causes an increased vasopermeability, increased expression
of endothelial adhesion molecules and in¢ltration of leukocytes,
signs of in£ammation (Wagener et al, 2001). These events appear
to be linked to the chronic in£ammation in venous leg ulcers.
The pro-in£ammatory e¡ects of heme induce expression of heme
oxygenase, an intracellular, heme-degrading enzyme (Panchenko
et al, 2000;Wagener et al, 2001). The products of the heme degra-
dation by heme oxygenase, CO, and bilirubin, have cyto-protect-
ing properties against oxidative stress (Otterbein and Choi, 2000).
It may be speculated that t-a1m, which seems to have its heme-
degrading property in common with heme oxygenase (Allhorn
et al, 2002), a¡ects heme in a similar way giving rise to these anti-
oxidative mediators.
Another product of heme degradation is, of course, free iron.
The results in this paper, in agreement with previous reports, de-
monstrate the presence of iron in the ulcer £uids, as well as iron
deposits in chronic wound sections. Interestingly, the levels of
iron (freeþ protein bound) were lower in wound £uids and plas-
ma from chronic ulcer patients than in normal plasma, whereas
iron deposits were seen in chronic wound tissue but not in acute
wound or normal tissue. This suggests that the iron-chelating
mechanisms are insu⁄cient in the in£ammatory tissue. Iron re-
presents an oxidative threat to the tissue components, but heme
oxygenase has been suggested to promote sequestering of the
iron into the storage protein ferritin, which serves a dual role by
hiding the iron and itself possesses a cyto-protective and anti-oxi-
dant activity (Balla et al, 1992; Otterbein and Choi, 2000; Ryter
and Tyrell, 2000). It may be speculated that a1m has a similar ef-
fect as heme oxygenase also in this case, promoting iron storage;
however, additional observations are necessary before any conclu-
sions can be drawn about the role of a1m in iron metabolism.
Unlike heme oxygenase, a1m operates extracellularly, possibly
providing the main source of protection against unsequestered
heme in the extracellular space. In conclusion, our results support
the concept of a1m as part of a novel endogenous defense me-
chanism against heme-induced oxidative stress.
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